Earnings Week Ahead: TSLA, GOOG, GE, BA, PG, PEP, ABBV, V, T, AAL, LUV, INTC, IBM, and More
What to Expect in the Week Ahead (Tesla, Alphabet Earnings; Global Flash PMI Reports)
Over 70% of Companies Deliver EPS Wins This Week: Earnings Scorecard
Catalyst Watch: Spotlight on Tesla, Alphabet Earnings, AACR Drug Data, and Global PMI Reports
A Congress Member Sold Up To $120K In AbbVie Stock: Here's What You Need To Know
$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today
Is AbbVie Inc. (ABBV) the Best Large-Cap Value Stock to Buy as the Recession Hits?
AbbVie (ABBV) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Guggenheim Maintains AbbVie(ABBV.US) With Buy Rating, Maintains Target Price $214
S&P 500 Falls on Week Led by Tech, Consumer Discretionary, Communication Services
Guggenheim Reiterates Buy on AbbVie, Maintains $214 Price Target
AbbVie Analyst Ratings
Fund Update: Bank Pictet & Cie (Europe) AG Added 78,930 Shares of ABBVIE ($ABBV) to Their Portfolio
Trump's New Order Targets Drug Pricing Transparency And Medicare Cost Reduction
AbbVie Inc. (ABBV): One of the Best Dividend Monarchs to Invest in Now
Top SA Quant-rated Healthcare Stocks as Q1 Earnings Unfold
Trump Targets Medicare Price Negotiations in New Executive Order
Tariffs Threaten Generic Drug Production and Supply - Fmr. FDA Commissioner
Unusual Options Activity: KEY, MRK and Others Attract Market Bets, KEY V/OI Ratio Reaches 243.0
AbbVie Options Trading: A Deep Dive Into Market Sentiment